INMB INmune Bio, Inc.: Forvard P/S multiplikatori
INmune Bio, Inc. (INMB) Altsgeymer kasalligiga qarshi kurashish uchun immunoterapiyalarni ishlab chiqishga ixtisoslashgan. Oldingi P/S koeffitsiyenti bozor kutganlarini tasdiqlaydi, bunda 767.40 darajasi joriy baholashni aks ettiradi. Tashqi tadqiqot markazlariga kuchli bog'liqlik qat'iy ichki nazorat bilan muvozanatga keltirilgan. Bundan tashqari, dori vositalarini ishlab chiqish iqtisodiy sikllarga bog'liq emas, bu esa makroiqtisodiy tebranishlarga yuqori chidamlilikni namoyish etadi.
INmune Bio Corporation (INMB) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning xususiy kapitalga nisbati INmune Bio, Inc.|INMB - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati INmune Bio, Inc.|INMB - Kompaniyaning jamlangan qarzi|Balans kapitallashuviga qarzlar INmune Bio Corporation|INMB - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli majburiyatlari INmune Bio|Tezkor likvidlik koeffitsiyenti inmunebio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
INMB - Kompaniyaning sof foydasi|Prognoz qilingan kelajakdagi foyda INmune Bio, Inc.|INMB - Biznesning o‘zini qoplash muddati|Kelajakdagi narxning foydaga nisbati INmune Bio Corp|INMB - O‘sish sur’atiga tuzatilgan narx-foyda|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti INmune Bio Corporation|INMB - Foizlar, soliqlar va amortizatsiya chegirilmasdan oldingi daromad|Bir aksiya uchun sof foyda (EPS TTM) INmune Bio|INMB - So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi inmunebio.com|INMB - Bu yil bir aksiya uchun foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi INmune Bio, Inc.
- sotuvlar va tushum ko'rsatkichlari:
Kompaniyaning fundamental baholanishi:INmune Bio INMB
Oldingi P/S ko'rsatkichi joriy bozor kapitalizatsiyasining prognoz qilingan daromadga nisbatini aks ettiradi, bu esa investorlarga bozor savdo kutib-kutishlari dinamikasini kuzatish va fundamental tendentsiyani tebranishlardan ajratish imkonini beradi. Ushbu oldingi narx-savdo grafikasi tahlili orqali, inqilobiy immunologik ishlanmalar salohiyati bilan aktivning yuqori baholanishi oqlanadigan Altsgeymer kasalligi terapiyasi sohasidagi INmune Bio, Inc. (INMB) innovatsiyalari uchun haddan tashqari ko'p to'lash xavfini baholash mumkin.
Raqobatchilar tahlili
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati ADMA Corp ADMA|Protagonist Therapeutics (PTGX) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati IMVT|Narxning prognoz qilingan daromadga nisbati Kiniksa|Forvard narx/daromad multiplikatori Grifols SA (GRFS)|Forvard narx/daromad multiplikatori ADPT (Adaptive Biotechnologies Corp)|Forvard P/S multiplikatori Celldex Corp (CLDX)|Narxning prognoz qilingan daromadga nisbati Aurinia Pharmaceuticals AUPH|BCRX: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Vera Therapeutics - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Dianthus Therapeutics Inc|PHVS (Pharvaris Corp) - Forvard narx/daromad multiplikatori|AbCellera Corp - Sotuvga nisbatan forvard narx|TRML (Tourmaline Bio, Inc.) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati PGEN|Forvard P/S multiplikatori PHAR|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Nektar Therapeutics Inc|Narxning prognoz qilingan daromadga nisbati Upstream Bio Corp UPB|Zenas Corp (ZBIO) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|IMNM: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx GOSS (gossamerbio.com)|KALV: Forvard P/S multiplikatori|SEPN - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Pieris Pharmaceuticals Inc|Kapitalizatsiyaning prognoz qilingan daromadga nisbati SVRA (Savara Pharma)|Forvard P/S multiplikatori RIGL|Forvard narx/daromad multiplikatori anaptysbio.com ANAB|Astria Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati enGene Holdings Inc (ENGN)|RAPT Therapeutics, Inc. - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Aerovate Therapeutics Inc JBIO|Aclaris Therapeutics (ACRS) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati KYTX|Narxning prognoz qilingan daromadga nisbati Tiziana Life Sciences Ltd|Forvard narx/daromad multiplikatori Cabaletta Bio Inc. (CABA)|Forvard P/S multiplikatori VTYX|Narxning prognoz qilingan daromadga nisbati THTX (Theratechnologies, Inc)|Narxning prognoz qilingan daromadga nisbati Avalo Therapeutics, Inc AVTX|ELDN (eledon.com) - Kelajakdagi narxning daromadga nisbati|Agenus Inc. - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx CLYM (Climb Bio Inc.)|ZURA: Forvard P/S multiplikatori|aTyr Pharmaceuticals (ATYR) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Adagene Inc|IMA: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Shattuck Labs, Inc. (STTK)|Forvard narx/daromad multiplikatori equilliumbio.com EQ|Forvard P/S multiplikatori CNTB (Connect Biopharma Holdings Limited)|Forvard P/S multiplikatori Immunic Therapeutics IMUX|ATRA: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx IFRX (InflaRx N.V.)|XFOR: Forvard P/S multiplikatori|ACET - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Celularity Inc|Forvard narx/daromad multiplikatori Barinthus Biotherapeutics Corp (BRNS)|Narxning prognoz qilingan daromadga nisbati Kezar Life Sciences (KZR)|Forvard narx/daromad multiplikatori sabbiotherapeutics.com SABS|Akari Therapeutics Plc - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori Enlivex Therapeutics Ltd ENLV|QTTB - Narxning prognoz qilingan daromadga nisbati|GOVX (GeoVax Corp) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|EDSA: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati ibioinc.com (IBIO)|CARM (Carisma Therapeutics Inc) - Forvard P/S multiplikatori|XTL Biopharmaceuticals Ltd (XTLB) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Bolt Biotherapeutics (BOLT)|hcwbiologics.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Aptevo Therapeutics Inc. APVO|AIM - Forvard narx/daromad multiplikatori|ADTX: Forvard narx/daromad multiplikatori|GRI - Forvard P/S multiplikatori|XORTX (XRTX) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati HIND|REVB (Revelation Biosciences) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati indaptusrx.com INDP|Forvard narx/daromad multiplikatori SCNI (Scinai Immunotherapeutics Ltd.)|CALI (calcimedica.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori AFMD (Affimed N.V.)|Allakos Inc - Narxning prognoz qilingan daromadga nisbati|HOOKIPA - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati IGM Biosciences, Inc. IGMS|iTeos Therapeutics, Inc. (ITOS) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Ocean Biomedical Inc (OCEA)|Forvard narx/daromad multiplikatori TCBP|THRD: Sotuvga nisbatan forvard narx
